Neurovance, Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Oct 2012 | $27 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Neurovance, Inc. had no revenue when it filed its newest notice of a funding round (Jun 2015).
SEC Form D (revenue range) · Jun 2015
The industry group it chose in its notices: Other Technology.
SEC Form D · Jun 2015
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Neurovance, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 7 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Albert L. Sokol | Secretary | Jun 2015 |
| Anthony A. McKinney | President and CEO | Jun 2015 |
| Brigitte T. Robertson | Chief Medical Officer | Jun 2015 |
| Franklin P. Bymaster | Chief Scientific Officer | Jun 2015 |
| William T. Pappafotopoulos | Chief Operating Officer | Jun 2015 |
| Walter T. Piskorski | Chief Operating Officer | Mar 2015 |
| Timothy T. Hsu | Executive officer | Aug 2014 |
| Pierre J. Tran | Executive officer | Apr 2013 |
| Thomas A. Shea | Executive officer | Apr 2013 |
| Anthony A. McKinney | President and CEO | Jun 2015 |
| Brigitte P. Smith | Director | Jun 2015 |
| Campbell P. Murray | Director | Jun 2015 |
| Daniel P. Omstead | Director | Jun 2015 |
| Paul P. Weiss | Director | Jun 2015 |
| Timothy J. Barberich | Director | Jun 2015 |
| TImothy J. Barberich | Director | Mar 2015 |
| Frank P. Gentile | Director | Aug 2014 |
| Joshua P. Funder | Director | Aug 2014 |